Roche CEO Thomas Schinecker joins Bloomberg's "The Opening Trade" to discuss his company's earnings and the timeline for the potential launch for Roche's blockbuster breast cancer pill that may become one of the company's biggest sellers by the end of the year.

Roche CEO Thomas Schinecker joins Bloomberg's "The Opening Trade" to discuss his company's earnings and the timeline for the potential launch for Roche's blockbuster breast cancer pill that may become one of the company's biggest sellers by the end of the year.

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Roche CEO Thomas Schinecker Talks Blockbuster Cancer Pill, Earnings

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/c9f8b759-ef88-444f-addc-b43500ea8f76/transcript